相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
Andrea Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
Jennifer Brewin et al.
BLOOD (2009)
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
Biagio De Angelis et al.
BLOOD (2009)
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids
R. A. McDonald et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant
Ana B. Oton et al.
LEUKEMIA & LYMPHOMA (2008)
Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children
Mary M. Taj et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Adoptive cellular immunotherapy for viral diseases
Y. Fujita et al.
BONE MARROW TRANSPLANTATION (2008)
Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab
A. D. Kirk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders
Fiona E. Craig et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation
Sylvain Choquet et al.
HAEMATOLOGICA (2007)
Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders - A histogenetic study
Lawrence R. Johnson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry
S. Caillard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen
Cecile Fohrer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 study
S Choquet et al.
BLOOD (2006)
Treatment of PTLD with rituximab or chemotherapy
RL Elstrom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities
M Djokic et al.
GENES CHROMOSOMES & CANCER (2006)
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: Long-term experience from a single center
AB Jain et al.
TRANSPLANTATION (2005)
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
DP Funch et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
S Caillard et al.
TRANSPLANTATION (2005)
Posttransplant lymphoproliferative disorder: Significance of central nervous system involvement
JF Buell et al.
TRANSPLANTATION PROCEEDINGS (2005)
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era
IM Ghobrial et al.
LEUKEMIA & LYMPHOMA (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Post-transplant lymphoproliferative disorder: a review
AW Loren et al.
BONE MARROW TRANSPLANTATION (2003)
Lymphomas occurring late after solid-organ transplantation - Influence of treatment on the clinical outcome
G Dotti et al.
TRANSPLANTATION (2002)
Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
VR Dharnidharka et al.
TRANSPLANTATION (2001)
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients
DE Tsai et al.
TRANSPLANTATION (2001)
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial
E Haddad et al.
BLOOD (2001)
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo:: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders
M Majewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient.
W Schmidt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders - A distinct entity?
BP Nelson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
